-
1561
A Risk Management Approach to Global Pandemics of Infectious Disease and Anti-Microbial Resistance
Published 2024-11-01Subjects: Get full text
Article -
1562
18 YAŞ ÜSTÜ VATANDAŞLARIN COVID-19 AŞI KARŞITLIĞI NEDENLERİNİN İNCELENMESİ
Published 2022-11-01Subjects: Get full text
Article -
1563
Neutralizing antibody test supports booster strategy for young individuals after SARS-CoV-2 Omicron breakthrough
Published 2025-01-01Subjects: Get full text
Article -
1564
-
1565
Biological properties of foot-and-mouth disease virus А 2205/G-IV strain
Published 2023-12-01Subjects: Get full text
Article -
1566
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
Published 2025-01-01Subjects: Get full text
Article -
1567
Diagnostic challenges in the diagnosis and treatment of ovarian cancer in Lynch syndrome
Published 2025-01-01Subjects: Get full text
Article -
1568
-
1569
Editorial: ticks & tick-borne parasites and diseases
Published 2024-08-01Subjects: Get full text
Article -
1570
Establishing a new human pneumococcal standard reference serum, MPRSS-01
Published 2025-01-01Subjects: Get full text
Article -
1571
Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection
Published 2025-01-01Subjects: Get full text
Article -
1572
-
1573
Key insights into recent advances and challenges in COVID-19 management
Published 2025-01-01Subjects: Get full text
Article -
1574
The Expressions of the Immunity- and Muscle Development-Related Genes of 40-Day-Old Broilers Are Promoted in Response to the <i>In Ovo</i> and Dietary Supplemental Administration of Calcidiol in Conjunction with the <i>In Ovo</i> Administration of Marek’s Disease Vaccine
Published 2024-12-01Subjects: Get full text
Article -
1575
-
1576
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study
Published 2025-01-01“…We investigated the safety, efficacy, and immunogenicity of the therapeutic DNA-based vaccine VB10.16 combined with the immune checkpoint inhibitor atezolizumab in patients with human papillomavirus (HPV)16-positive r/m cervical cancer.Patients and methods This multicenter, single-arm, phase 2a study (NCT04405349, registered 26 May 2020) enrolled adult patients with persistent, r/m HPV16-positive cervical cancer. …”
Get full text
Article -
1577
-
1578
Immunogenic dying cells elicit potent anti-tumor T cell immunity against lung metastasis and tumorigenesis
Published 2025-01-01Subjects: Get full text
Article -
1579
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
Published 2025-01-01Subjects: Get full text
Article -
1580
Tissue‐resident memory T cells in diseases and therapeutic strategies
Published 2025-01-01Subjects: Get full text
Article